C-Path European Nonprofit Established in Amsterdam
C-Path in Europe works seamlessly with its U.S. counterpart to advance the development of novel regulatory-endorsed methodologies to accelerate medical product developmentContinue reading
C-Path in Europe works seamlessly with its U.S. counterpart to advance the development of novel regulatory-endorsed methodologies to accelerate medical product developmentContinue reading
Scottsdale, AZ, March 22, 2022— Life365, a Microsoft Partner and leading Virtual Care and Remote Patient Monitoring (RPM) platform, announced today the integration into Microsoft Cloud for Healthcare, empowering Providers and Payors to connect and scale to larger patient populations in low-cost settings, typically at home.Continue reading
Laboratory experiments at Princeton University and TGen, testing a ketogenic diet, lead to nationwide clinical trial
The rise in virtual care has opened the door for healthcare delivery transformation. This rise can be linked back to the pandemic, and new reimbursement opportunities for remote care services, which have fueled the adoption of digital health technologies, including remote patient monitoring.Continue reading
The Arizona Commerce Authority understands that the cost of travel and accommodations may not be feasible for everyone, so they are offering a registration reimbursement
Named for a respected Arizona scientist, this trial uses a combination of drugs against advanced cancer in patients where other treatments have failed
WASHINGTON, D.C. (March 17) — In a letter transmitted today, the Bayh-Dole Coalition and nearly 100 prominent academic and private sector innovation experts and organizations, public policy associations, and legal scholars urged U.S. Department of Health and Human Services Secretary Xavier Becerra to reject the latest march-in petition on prostate cancer drug Xtandi.Continue reading
PathogenDx Appoints Foremost Industry and Topic Experts as Its Advanced Microarray Testing Platform Sets New Standards in DNA-Based TestingContinue reading
Study offers therapeutic expansion phase for patients with a positive pharmacokinetic response to investigational drug